These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 2463720

  • 1. [Diprafenone--comparative study of anti-arrhythmia therapy with propafenone].
    Geibel A, Zehender M, Hohnloser S, Landsrath C, Meinertz T, Just H.
    Z Kardiol; 1988 Jul; 77(7):464-9. PubMed ID: 2463720
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of chronic ventricular arrhythmias with the new class Ic anti-arrhythmia agent diprafenon--results of long-term therapy].
    Heuer H, Gülker H, Hasfeld M, Frenking B, Behrenbeck T.
    Z Kardiol; 1987 Jul; 76(7):415-20. PubMed ID: 3673163
    [Abstract] [Full Text] [Related]

  • 3. [Propafenone in ventricular hyperkinetic arrhythmias. Dynamic ECG evaluation of the acute oral test and short-term treatment].
    Garimoldi M, Sghirinzetti M, Pirastu A, Cappiello E, Sala R, Terranova P.
    G Ital Cardiol; 1986 Apr; 16(4):328-32. PubMed ID: 2427383
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
    Gülker H, Thale J, Olbing B, Heuer H, Frenking B, Bender F.
    Arzneimittelforschung; 1985 Apr; 35(9):1387-93. PubMed ID: 4084340
    [Abstract] [Full Text] [Related]

  • 8. [Significance of cardiac arrhythmias in the aged and their treatment with propafenone controlled by plasma level].
    Lachnit KS, Rieder L.
    Z Gerontol; 1985 Apr; 18(6):343-52. PubMed ID: 2420079
    [Abstract] [Full Text] [Related]

  • 9. [Comparative studies of tocainide and propafenone in the treatment of ventricular arrhythmias].
    Gebhardt A, Schmuderer R, Hilpert P.
    Arzneimittelforschung; 1984 Apr; 34(3):303-6. PubMed ID: 6428425
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A, Adragão P, Bonhorst D, Seabra-Gomes R.
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Electrophysiologic effects of diprafenone in supraventricular and ventricular tachycardia].
    Manz M, Beermann J, Gerckens U, Lüderitz B.
    Z Kardiol; 1986 Dec; 75(12):757-63. PubMed ID: 3825226
    [Abstract] [Full Text] [Related]

  • 16. [Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine].
    Zehender M, Geibel A, Hust M, Hohnloser S, Meinertz T, Just H.
    Z Kardiol; 1987 Aug; 76(8):501-6. PubMed ID: 2445118
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Propafenone in ventricular extrasystole in elderly patients. Tolerance and efficacy].
    Camous JP, Benoit P, Vrancea F, Gibelin P, Schenowitz A, Baudouy M, Varenne A, Morand P.
    Ann Cardiol Angeiol (Paris); 1987 Apr; 36(4):179-82. PubMed ID: 2438971
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.